2ND-5TH SEPTEMBER 2018 | AMSTERDAM
Meet the iOnctura team at the following events:
2ND-5TH SEPTEMBER 2018 | AMSTERDAM
4TH-5TH OCTOBER 2018 | CONGRESS CENTER BASEL | SWITZERLAND
16TH OCTOBER 2018 | LONDON | UK
5TH-7TH | NOVEMBER 2018 | COPENHAGEN | DENMARK
14TH-15TH | NOVEMBER 2018 | LONDON | UK
27TH-29TH | NOVEMBER 2018 | BERLIN | GERMANY
Watch and Listen to iOnctura CEO, Catherine Pickering outline the roadmap for the immuno-oncology startup
Geneva, Switzerland, 28 November 2017: iOnctura SA, a recently founded late stage preclinical immuno-oncology company, announced today the formation of an international Scientific Advisory Board (SAB)…
iOnctura is set up to develop a pipeline of assets targeting immunosuppression in the tumour microenvironment. The company will progress its portfolio of assets seamlessly into clinical evaluation, in collaboration with one of its shareholders Cancer Research…